Sukhatme Mayukh sold ROIV
October 16, 2026 · Form 4 insider transaction
Sukhatme Mayukh sold 19,976 shares of Roivant Sciences Ltd. at $33.53 per share, a transaction worth $669.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Represents the "net settlement" by the Issuer of performance restricted stock units ("PSUs"), previously granted to the reporting person on July 26, 2024, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The Common Shares issued on settlement of the PSUs (excluding those withheld for tax withholding obligations, as described above) remain subject to a two-year holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied.